Healthcare Regulatory Affairs Outsourcing Market Report Predicts Impressive Growth by 2030 just published

Healthcare Regulatory Affairs Outsourcing Market

The healthcare regulatory affairs outsourcing offers medical writing and publishing which plays an important role to develop high-quality documents for the clinical research process. The rising, increasing number of patent expirations and growing research and development activities are some factors that are likely to propel the market growth during the assessment period.

The healthcare regulatory affairs outsourcing market size is expected to reach USD 9.8 billion by 2030 at 9.4% CAGR during the forecast period 2022-2030. 

Additionally, the rising incidence of several chronic diseases such as cancer and other infectious diseases have encouraged biopharmaceutical companies to develop a large number of new products. This rising development of products in clinical trials, the demand for clinical trial application and product registration services is increasing, thus driving the growth of this market. For instance, the International Federation of Pharmaceutical Manufacturers & Associations stated that around 1,919 and 1,308 drugs are in development for cancer and neurology, respectively. Additionally, IFPMA stated that in 2014, there were 401 drugs in the pipeline for diabetes and 208 drugs in development for HIV/AIDS. Furthermore, IFPMA specified that their members have 119 ongoing R&D projects related to neglected tropical diseases.

Major Key Players:

Some Of The Healthcare Regulatory Affairs Outsourcing Market Players are Accell Clinical Research, LLC, Charles River Laboratories International, Inc., Clinilabs, Inc., Criterium Inc., ICON plc, Covance, Inc., Medpace, Inc., PAREXEL International Corporation, Pharmaceutical Product Development, (PPD) LLC, Promedica International, Quintiles Transnational Corporation, WuXi App Tec, and others.

Segment Analysis

The global Healthcare Regulatory Affairs Outsourcing Market is segmented into application, product and end user. On the basis of application, the market is segmented into therapy, research and cell, and tissue banking. The global Healthcare Regulatory Affairs Outsourcing Market by product is segmented into stem cell lines, instruments, consumables and culture media. The stem cell lines segment is expected to lead the market and register a substantial CAGR to reach USD 9,366.9 million by the end of 2023. Due to its unique capabilities for tissue repair, replacement, and regeneration is expected to drive the market growth. On the basis of end user, the market is segmented into pharmaceutical/biotechnology companies & CRO and hospitals & stem cell banks.

Regional Analysis

Geographically, the global Healthcare Regulatory Affairs Outsourcing Market has been segmented into  Regulatory Affairs Outsourcing Market, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for Carotid Artery Disease Market in 2017 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. Major factors influencing the growth of the market include the presence of major manufacturers, growing prevalence of cancer, growing healthcare expenditure, and increase in technologically-advanced products in Europe are driving the growth of the Healthcare Regulatory Affairs Outsourcing Market in the region. The Asia-Pacific Healthcare Regulatory Affairs Outsourcing Market is one of the fastest growing regions across the globe. Growing population and rising incidence of cancer are likely to drive the growth of the Asia-Pacific market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiac Biomarkers Market Players, Analysis and Forecast to 2030 Detailed in New Research Report

Cardiac Biomarkers Market

The key factors that drive the cardiac biomarkers market are the increasing prevalence of cardiovascular diseases and lifestyle diseases, increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment & research in which cardiac biomarkers are used, technological advancements in cardiac biomarkers, and favorable government initiatives to create awareness related to cardiovascular diseases. However, a lack of awareness among people is expected to hamper market growth.

The Cardiac Biomarkers Market is expected to reach USD 11.12 Billion by 2030 at 13.90% CAGR during the forecast period 2022-2030There are a number of factors that impact the growth of the cardiac biomarkers market. Some of the key factors include a rise in demand for diagnostic and testing of various cardiovascular diseases, development and advancement in cardiac biomarkers, and growth in the patient population suffering from cardiovascular diseases. Other key growth drivers include the rise in the number of new cardiovascular cases diagnosed each year and the increase in demand for disease-specific treatment in which cardiac biomarkers are used. The increasing prevalence of cardiovascular diseases is expected to boost the cardiac biomarkers market during the forecast period.

Major Key Players:

Some of the Cardiac Biomarkers Market Players are Novartis Ag, Quidel Corporation, ACS Biomarker B.V., Randox Laboratories Ltd., Trivitron Healthcare, F. Hoffman La Roche Ltd., Johnson & Johnson Services Inc., Abbott Laboratories, Siemens, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, and Biomérieux Sa.

Segment Analysis

The cardiac biomarkers are widely used as an integrated diagnostic approach for various cardiovascular diseases. The market has been segmented based on cardiac biomarker type - Creatine Kinase (CK-MB), Troponins T and I, myoglobin, BNPs, IMA, and others. Troponins I and T isthe highest revenue-generating segment in the overall cardiac biomarker market due to theirprodigious specificity and theirability to accurately detect the cardiac events of Acute Coronary Syndrome (ACS). It is also anticipated to exhibitthe highest growth during the forecast period.

Based on application, the market is segmented into myocardial infarction(MI), congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Myocardial infarction (MI) holds the highest market share, followed by Acute Coronary Syndrome (ACS) due to the highest prevalence rate among cardiovascular diseases (CVDs). Myocardial infarction is projected to grow at the highest CAGR of 11.5% during the study period.

The location of the testing segment is classified as point-of-care testing and laboratory testing. Doctors and clinicians largely prefer point-of-care cardiac testing for rapidpatientmonitoring with chest pain in an emergency care unit, resulting inthe highest CAGR. Laboratory testing is expected to grow at a significant CAGR of 9% during the period of 2020 to 2030.

Regional Analysis

Based on region, the global cardiovascular biomarkers market is segmented into the Americas, Europe, Asia-Pacific, and MEA. The Americas leads the global market due to the high CVD prevalence rate, high demand for cardiac testing, and rising awareness aboutcardiac diagnostics solutions. Asia-Pacific is expected to register the highest CAGR due to increasing disposable incomes,modernization, and rising affordability for advanced cardiac treatments.

The Americas dominated the cardiac biomarker market in 2019 and is likely to continue to command during the assessment period. This can be attributed to the high prevalence of cardiovascular diseases & diabetes, product launch, and acquisition in this region. As per the Centers for Disease Control and Prevention, heart disease is one of the leading causes of death in the US. Around 655,000 Americans die from heart disease each year, or one person dies every 36 seconds in the US from cardiovascular disease. Heart disease costs the US about USD 219 billion each year from 2014 to 2015. Furthermore, the key players in the regional market are also focused on product development and launch to expand their product portfolio.

Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2020 to 2030. This is owing to the high incidence of cardiovascular diseases, COPD, and diabetes. As per the American Diabetes Association, more than 60% of the entire diabetic population lives in Asia. India and China are highly populated countries.

Moreover, various initiatives taken by the governments in Asia-Pacific to support the healthcare system are also fueling the regional market's growth. For instance, in August 2020, the Government of India announced a national health ID for every Indian to create a centralized mechanism to identify every participating user in the National Health Stack uniquely. Furthermore, the rising per capita disposable income of middle-class families, which accounts for a large population in Asia, results in individuals spending more on health. This is driving the growth of the cardiac biomarkers market in the region during the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Cyber Security Market Players, Analysis and Forecast to 2030 Available in New Report

Healthcare Cyber Security Market

Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime.

The Healthcare Cyber Security Market is expected to grow at CAGR of 17.3% to reach USD 55.7 Billion by 2030.

Healthcare Cyber Security Growth Boosters

The global healthcare cybersecurity market is estimated to put a strong foundation of propelling growth on the increasing need for network security, a type of IT security widely sought by healthcare organizations. Access control and distributed denial-of-service (DDoS) mitigation are some of the extremely sophisticated types of network security solutions that ensure esteem protection.

Interestingly, the end-user expenditure on the healthcare cybersecurity market is prognosticated to continue seeing an ascend owing to its mounting awareness. In the year 2016, network security displayed a maximum performance in the market. Other types of security, such as cloud, wireless, and application, could also contribute to the overall growth in the future.

While cyber-attacks are prophesied to be amongst the crucial drivers of growth in the global healthcare cybersecurity market, data breaches could be in the run. An escalating count of healthcare institutions is also expected to take to cybersecurity solutions to protect patients and their data as well. The implementation of connecting medical devices and digital medical record systems coupled with the surging practice of tablets, laptops, Smartphones, and other devices is foretold to set the tone for a valuable demand in the market.

As observed, in the current time, cybersecurity technologies and solutions are evolving owing to the changing threat landscape, where threats are becoming smarter and destructive. In today’s connected health environment, cybersecurity is no longer an option or afterthought, whereas it is a powerful strategic asset that is being addressed by every organization.

Furthermore, some of the other key factors driving the healthcare security market are the escalating cyber-attack threat. Recent estimates by MRFR suggest that in the period from 2010 to 2014, approximately 37 million healthcare records were compromised in data breaches. Moreover, mount in patent infringement cases, medical identity fraud, business records, and loss of patient health records is expected to boost the healthcare cybersecurity market during the forecast period.

On the contrary, the factor of lack of awareness about cybersecurity related to the healthcare industry would act as a limiting factor, thereby hampering the growth of the healthcare cybersecurity market.

Major Key Players:

MRFR recognizes the following Healthcare Cyber Security Market Players are —Cisco Systems, Inc. (US), IBM (US), McAfee, LLC (Canada), Symantec Corporation (US), FireEye, Inc. (US), Palo Alto Networks, Inc. (US), DXC Technology Company (US), Trend Micro Incorporated (Japan), Booz Allen Hamilton Inc. (US), and SENSATO CYBERSECURITY SOLUTIONS (US).

Segment Analysis

The Global Healthcare Cyber Security Market has been segmented into threat type, solution type, and end user. By threat type, the market has been segmented into distributed denial-of-service (DDOS), malware, advanced persistent threat (APT), and others. Based on solution type, the global healthcare cybersecurity market has been segregated into risk and compliance management, antivirus and antimalware, security information and event management (SIEM), DDOS mitigation, identity and access management, and others.

Regional Analysis

The Global Healthcare IT Security Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are expected to hold the largest share of the global healthcare cybersecurity market. This is owing to the increasing case of data breaching, rising cyberattacks on pharmaceutical companies, and healthcare facilities are boosting the market growth in this region.

The Europe market holds the second-largest position in the global healthcare cybersecurity market due to the high spending on healthcare IT, the presence of a large number of pharmaceutical companies, and innovation of new software to protect the healthcare data boosts the market growth in this region. 

Asia-Pacific is estimated to be the fastest-growing region owing to the rapid development in technology, and the presence of enormous opportunities for the development of the market drives the growth of the Asia-Pacific healthcare cybersecurity market.  

The healthcare cybersecurity market in the Middle East & Africa accounts for the least market share due to the adequate healthcare infrastructure support accounted for a relatively smaller market share in 2018.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Uveitis Treatment Market Players, Industry Size, Share, Analysis and Forecast 2022 – 2027

Uveitis Treatment Market

Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis.

Uveitis Treatment Market is expected to reach USD 764.5 Million at a CAGR of 5.6% during the forecast period.

Uveitis is an eye conditions, an inflammation of the middle layer of the eyeball, called the uvea. Uveitis is manifested through symptoms such as redness of the eye, pain, and blurred vision. These are the prime symptoms of uveitis. The disease usually occurs in people aged 20 to 50 and can cause significant distress due to the pain and blurry vision caused by the problem. The growing prevalence of uveitis is the major driver for the global uveitis treatment market over the forecast period from 2019 to 2025. The growing prevalence of uveitis is due to the increasing threat of air pollution, which is a major causative factor for the inflammation of delicate body parts such as the inner regions of the eye. This is likely to remain a major driver for the uveitis treatment market over the forecast period, as growing urbanization around the world is likely to intensify the problem of air pollution in the coming years.

Increasing expenditure on R&D to find solutions for uveitis is likely to be a major driver for the global uveitis treatment market. The increasing awareness about uveitis among the general populace is the key driver for this phenomenon, as this has driven the demand for effective cures for the condition. Increasing product launches in the uveitis treatment market are also likely to remain a major driver for the market over the forecast period. On the other hand, the widespread use of corticosteroid drugs is likely to be the major restraint on the market, as there are various side effects of corticosteroid drugs that patients want to avoid.

Major Key Players:

Some of the key players in the Global Uveitis Treatment Market Players are Allergan PLC, Novartis AG, Bausch Health, EyePoint Pharmaceuticals, Inc., AbbVie Inc., Horizon Therapeutics PLC, Mylan N.V., and Alimera Sciences.

Segment Analysis

The global uveitis treatment market has been segmented based on type, drug class, and end-user.

The market, based on type, has been divided into anterior uveitis, intermediate uveitis, , posterior uveitis treatment and others. The anterior uveitis is likely to hold maximum market share in the global uveitis treatment market.

The global uveitis treatment market based on drug class has been segregated into corticosteroid drugs, anti-inflammatory drugs, immunosuppressive drugs, and others. The corticosteroids drugs segment is anticipated to hold the largest share in the market due to the rising preference in the treatment of uveitis.

The end-user segments of the market are hospitals, specialty clinics, and others. The hospital's segment is expected to hold the largest share of the market, as these are the primary locations where patients receive treatment.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold the largest market share owing to the increasing prevalence of uveitis, the presence of a well-established healthcare sector, and high R&D expenditures. The uveitis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European uveitis treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The uveitis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a large patient pool and expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing. The uveitis treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Bioelectric Medicine Market, Global Synopsis & Forecast – 2030

Bioelectric Medicine Market

The bioelectric medicine market can anticipate reaching USD 31.65 billion by 2030 while attaining a 6.46% CAGR from 2022 to 2030, reveals Market Research Future (MRFR).

Primary Boosters and Restraints

By combining bioengineering, molecular medicine, and neurology, bioelectric medicine creates nerve-stimulating devices for the control of biological processes during disease treatment. The main factor projected to drive the market is the increased prevalence of chronic diseases like cardiac and neurological problems. According to the CDC, over 610 thousand Americans per year pass away from cardiac problems. About 370 of them pass away from coronary heart disease (CHDs). Due to the high demand for advanced bioelectric medicine to treat these chronic diseases, the market is anticipated to grow quickly.

The increased incidence of chronic and acute illnesses, the rapidly aging population, product advancements, and initiatives by significant businesses and organizations are some of the key growth drivers for the worldwide market. For instance, the first Bioelectronic Medicine Day, which featured a public health campaign, was instituted by the Alliance for Advancing Bioelectronic Medicine in January 2022. The campaign helped to encourage efforts and advancements in the field of bioelectronic medicine.

Cardiovascular Diseases (CVDs) are a significant cause of death in the U.S., says the CDC study from 2017. It's probable that CVDs are to blame for one-fourth of all fatalities. More than 80% of all CVD-related deaths are caused by stroke and IHD. In addition, by 2030, the economic cost of CVDs is projected to be over USD 1,044 billion. Other significant drivers of the market's expansion are manufacturers' increasing R&D expenditures and the rate at which new electroceuticals and bioelectric medications are approved by regulatory agencies.

Major Key Players:

Abbott, Cochlear Ltd, LivaNova PLC, ElectroCore, Inc., Medtronic Plc, Sonova, Nevro Corp., Boston Scientific Corporation, Stimwave LLC, Biotronik SE & Co KG are a Bioelectric Medicine Market Players.

Segment Analysis

By Type

Implantable Electroceutical Devices as well as Non-invasive Electroceutical Devices are the major types of bioelectric medicines.

By Product

Cardiac Pacemakers, Implantable Cardioverter Defibrillators, Spinal Cord Stimulators, Cochlear Implants, Transcutaneous Electrical Nerve Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, and others are the key products specified in the report.

By Application

Sensorineural Hearing Loss, Epilepsy, Pain Management, and Arrhythmia are some of the main applications of bioelectric medicines.

By End User

ASCs, Hospitals & Clinics, and others are the market end-users listed in the study.

Regional Analysis

Out of all the regions, the bioelectric medicine market will perform tremendously well in North America, given the increased prevalence of chronic diseases like cardiovascular and neurological disorders. The CDC estimates that heart disease causes about 610 thousand deaths in the US each year. The cause of death for about 370 of them is coronary heart disease. Because of the increased need for improved bioelectric therapy to treat these persistent illnesses, the market is anticipated to develop. Additionally, North America dominated the market in 2021 due to the presence of medical device producers like Abbott (US) and Boston Scientific Corporation (US).

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hyperspectral Imaging System Market – Global Industry Share Report 2022

Hyperspectral Imaging System Market

According to MRFR analysis, Hyperspectral Imaging System Market will grow at CAGR of 18.10% to hit $ 15582.37 Million by 2030.

Hyperspectral imaging system has wide applications in areas such as art conservation, vegetation, water resource control, archaeology, food quality, forensic medicine, crime scene detection, and forensic medicine. HSI technology is mainly used by the defence sector, government agencies, and non-military application sectors such as agriculture and mineral.

The growth of the global hyperspectral imaging system market is boosted by various factors such as the growing industrial applications of hyperspectral imaging, Technological advancements in electronics industry, such as sensor design, high spectral resolution, high spatial resolution, compact and lightweight devices, growing prevalence of cancer, and increasing awareness of innovative diagnostics methods.

Additionally, the introduction of innovative products in the market is expected to drive the growth of the market during the forecast period. For instance, In January 2020, Specim, Spectral Imaging Ltd. (Finland), launched Specim’s new AFX10, a compact hyperspectral camera for airborne use. Specim’s new AFX10 is easy to use and can be used to check water quality, estimating the fertilizing need in agriculture, identifying vegetation species, or studying wildlife population

However, the high cost associated with the use of hyperspectral imaging and scarcity of qualified professionals is likely to hamper the growth of the market during the forecast period.

Several market players currently dominate the global hyperspectral imaging system market. The key players are engaged in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Hyperspectral Imaging System Market Players are Headwall Photonics, Inc. (the US), Specim, Spectral Imaging Ltd. (Finland), Norsk Elektro Optikk as (NEO) (Norway), Resonon, Inc. (the US), Corning Incorporated(US), Telops (Canada), Applied Spectral Imaging(US), Bayspec, Inc.(the US), Surface Optics Corporation (US), Chemimage Corporation (US), Cubert GmbH (Germany), Raytheon (US), Galileo Group, Inc.(the US), Hypermed Imaging, Inc.(the US), Inno-Spec (Germany), Camlin Group Ltd. (UK), IMEC (Belgium), XIMEA GmbH (Germany), among others.

Segment Analysis

The Global Hyperspectral Imaging System Market has been segmented based on Product, Technology, and Application.

The market, based on product, has been divided into visible/near-infrared (VNIR), short-wave infrared (SWIR), mid-wave infrared (MWIR), long-wave infrared (LWIR). The Visible/Near-Infrared (VNIR) systems segment is likely to be the largest due to the high adoption of visible/near-infrared (VNIR) systems in various industries. The mid-wave infrared (MWIR) segment is predicted to be the fastest-growing due to increasing awareness about the rising adoption of MWIR systems in detecting volcanic vents, industrial gas leaks, or biomass burning events.

The global hyperspectral imaging system market has been segmented, based on the technology, into push broom, snapshot, and hyperspectral imaging camera others. The push broom segment is anticipated to be the largest segment during the forecast period due to the rising popularity of these devices owing to the simplified illumination requirements, minimized illumination exposure, high spectral resolution, and heat load, and the shorter capturing time.

The applications segment of the global hyperspectral imaging system market surveillance, remote sensing, machine vision/optical, and medical diagnostics. The surveillance segment is likely to hold the maximum share during the forecast period due to the rising adoption of innovative technologies in the defense sector.

Regional Analysis

The Market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas held the maximum share in the year 2018, owing to the presence of established key players in countries such as the US and Canada. The hyperspectral imaging system market in the Americas has further been categorized into North America and Latin America, with the North American market further divided into the US and Canada. The European hyperspectral imaging system market has been categorized as Western Europe and Eastern Europe. The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hyperspectral imaging system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hyperspectral imaging system market in this region is anticipated to be the fastest growing during the assessment period due to the rising mining activities, and blooming healthcare, agriculture, and biotechnology sector in the region. The hyperspectral imaging system market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Organ-on-a-chip Market Players, Size, Share, Analysis and Forecast-2030

Organ-on-a-chip Market

Organ-On-a-Chip Market (OOC) is expected to hold a value of USD 115.9 Million by 2030 at a CAGR of 11.80%.

Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate crucial physiological functions of body organs. These cells are placed in an environment that artificially replicates aspects of the human body, such as morphology, movement, flow, electrical stimuli, and liquid gradients.

The global organ-on-a-chip market is growing owing to various reasons, such as an increase in the number of collaborative sales agreements between pharmaceutical companies and university spin-offs and the availability of advanced models of OOCs in the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this market during the review period.

Grants by government and non-government entities have been the key drivers for the global OOC industry to date. The ability of OOC models to reduce drug development costs drastically will be a key market driver, which is also expected to fuel market growth. However, stringent drug regulatory processes constitute a significant restraint for the widespread use of OOCs by pharmaceutical companies. Drug regulatory authorities scrutinize the preclinical and clinical investigational data of a drug molecule to validate and approve it. The data generated by testing the drug in animal models and humans are required for the drug approval process.

At present, the regulatory authorities do not consider the data obtained by testing the drugs on OOCs sufficient for approval. Data predicting the efficacy of a drug molecule obtained by the chips can be submitted but only along with the trial data from animal and human subjects for the approval process. These drug regulations limit the use of OCCs by end-users are expected to hinder the growth of the global organ-on-a-chip market.

Several market players currently dominate the global organ-on-a-chip market. The key players are involved in product launches and acquisitions to strengthen their market positions.

Major Key Players:

Some of the Organ-on-a-Chip Market Players are CN Bio Innovations Limited (UK), Emulate, Inc. (US), TissUse GmbH (Germany), MIMETAS BV (Netherlands), Hµrel Corporation, Nortis, Inc. (US), InSphero (Switzerland), TARA Biosystems, Inc. (US), Axosim (US), Organovo Holdings Inc. (US), BioIVT (US), and HemoShear Therapeutics, LLC (US).

Segment Analysis

The global organ on a chip market has been segmented based on organ type, application, and end-user.

The global organ-on-a-chip market has been segregated, based on organ type, into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain barrier-on-chip, human-on-chip, and others.

The market based on application has been branched into drug discovery, toxicology research, and others. The drug discovery segment is expected to hold the largest share of the market due to the increased application of OOCs by pharmaceutical companies in drug discovery and clinical trials for the different chronic therapeutic areas. The toxicology research segment holds the second-largest share owing to increased R&D, government initiatives and funding for research institutes, and universities on OOCs in toxicology research and drug testing.

By end-user, the market has been classified as pharmaceutical companies, research organizations, and others. The pharmaceutical company’s segment is the largest segment owing to the rise in the number of pharmaceutical companies using OOCs for their R&D and drug toxicity and efficacy testing. The research organization segment is the second-largest segment owing to major universities, research organizations, non-profit research centers that are focusing on the application of OOCs in drug toxicology testing. For instance, the Wyss Institute received almost USD 5.6 million in grant money from the US FDA to use its organ-on-chip technology to test human physiological responses to radiation and to evaluate drugs designed to counter those effects in 2017.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the high prevalence of chronic diseases. The organ-on-a-chip market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European organ-on-a-chip market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The organ-on-a-chip market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Asia-Pacific is the fastest-growing region in the market. This is mainly due to the increased application of OOCs for drug screening for the treatment of various chronic diseases and a supportive regulatory framework in Asia-Pacific. Such favorable factors are expected to boost market growth during the forecast period.

The organ-on-a-chip market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com